MMT Premium · Tuesday + Friday Intelligence Brief
Week of April 11, 2026
HHS/ONC funding shift; DHA Data Governance protest cleared; ADVOCATE in evaluation
Top 3 Signals This Week
Signal 1
HHS budget hearing season opens — ONC funding realignment signals deregulation push
Administration officials begin testifying before Congress on the FY2027 budget request the week of April 14. HHS Secretary Kennedy appears before House Ways and Means and House Appropriations on April 16. The HTI-5 proposed rule — which would deregulate certain health IT certification requirements and advance AI interoperability standards — closed its comment period in February. ONC's grant and cooperative agreement programs are being restructured to align with the administration's deregulation posture. Firms relying on ONC-funded programs should monitor the appropriations markup for funding continuity signals.
Signal 2
ARPA-H ADVOCATE proposals in — award decisions expected by June
Full proposals for ARPA-H's ADVOCATE program closed April 1. Multiple awards expected via Other Transaction agreements for the 39-month agentic AI cardiovascular care program. Phase 1A performers will be announced in Q3 FY2026. This is one of the first federal programs to explicitly fund agentic AI systems in clinical settings with FDA engagement built into the program structure. Award announcements will signal which clinical AI teams the government considers credible for autonomous health applications.
Signal 3
DHA Data Governance protest dismissed — award expected imminently
The GAO protest on DHA's Data Governance solicitation (HT001126RE011) was filed by BDR Solutions, LLC and dismissed on March 30 (B-424295.1). With the protest cleared, DHA can proceed to award on the ~$34M WOSB set-aside for enterprise data catalog and metadata management. Firms in the evaluation should prepare for a rapid award decision. This contract covers baseline data inventory, metadata repository, and automated harvesting tools under the VAULTIS framework — foundational work that will shape DHA's data infrastructure for years.
New Opportunities
Cleared DHA Data Governance (HT001126RE011)
GAO protest dismissed Mar 30 · WOSB · ~$34M · Award pending
Award imminent
SOL ARPA-H ADVOCATE (ARPA-H-SOL-26-142)
Full proposals closed Apr 1 · OT agreements · Multiple awards
Evaluating
Evaluating CCN Next Gen Medical IDIQ
$700B ceiling · 10-year · Proposals closed Mar 16
No timeline
Awards & Status Changes
- DHA Data Governance (HT001126RE011): GAO protest (B-424295.1, BDR Solutions) dismissed March 30. Award path now clear on the ~$34M WOSB set-aside.
- ARPA-H ADVOCATE: Full proposals closed April 1. Evaluation underway. Multiple OT awards expected Q3 FY2026.
- CCN Next Gen Medical: Still in evaluation. No timeline announced for award decisions on the $700B IDIQ.
- VA EHRM Michigan: April go-live on track. Four sites in final readiness phase. First wave of 2026 deployments.
- HHS Budget: Hearings begin April 14 (House Budget Committee) and April 16 (HHS Secretary Kennedy before Ways and Means and Appropriations). Watch for ONC and ARPA-H funding signals.
What to Do Before Monday
- If you’re tracking DHA Data Governance: The protest dismissal clears the path to award. If you’re in the evaluation, prepare your team for a rapid start — the POP begins immediately upon award.
- If you depend on ONC programs: Monitor the April 16 HHS hearings. The HTI-5 deregulation posture and ONC funding realignment could change certification requirements that affect your product roadmap.
- If you submitted on ADVOCATE: Begin identifying potential Phase 1A subcontracting and teaming needs. Award decisions will move fast once evaluations conclude.
This brief is for Premium members
Premium members receive the full Twice-weekly intelligence brief by email and can access every archived issue.
Start Premium